Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Retina (Philadelphia, Pa.)|May 16, 2019
RAPID MACULAR CAPILLARY LOSS IN PATIENTS WITH UNCONTROLLED TYPE 1 DIABETESCarlo Lavia, Sylvie Feldman-Billard, Ali Erginay, et al.
Ophthalmology|March 17, 2004
Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trialPascale Massin, François Audren, Belkacem Haouchine, et al.
Acta Ophthalmologica Scandinavica|September 13, 2006
Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trialFrançois Audren, Ali Erginay, Belkacem Haouchine, et al.
American Journal of Ophthalmology|March 18, 2008
Dome-shaped macula in eyes with myopic posterior staphylomaDavid Gaucher, Ali Erginay, Amelie Lecleire-Collet, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 21, 2022
Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular EdemaThi Ha Chau Tran, Stephane Verdun, Jean François Le Rouic, et al.
American Journal of Ophthalmology|September 19, 2006
Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mgFrançois Audren, Amélie Lecleire-Collet, Ali Erginay, et al.
Retina (Philadelphia, Pa.)|December 23, 2016
CORRELATION BETWEEN CYSTOID SPACES IN CHRONIC DIABETIC MACULAR EDEMA AND CAPILLARY NONPERFUSION DETECTED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHYValérie Mané, Bénédicte Dupas, Alain Gaudric, et al.
Investigative Ophthalmology & Visual Science|September 29, 2004
Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edemaFrançois Audren, Michel Tod, Pascale Massin, et al.
Pageof 7